abstract |
The present invention discloses methods for producing antibodies against human metapneumovirus (HMPV) polypeptides, including antibodies that immunospecifically bind to HMPV-F protein. The present invention also discloses a method for preventing, treating or ameliorating symptoms associated with HMPV infection. |